Yoan Lamarche

Dr. Yoan Lamarche

Montreal Heart Institute/Université de Montréal

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
ANAnthony Nguyen
Anthony Nguyen
WFWilliam Fortin
William Fortin
AMAmine Mazine
Amine Mazine
DBDenis Bouchard
Denis Bouchard
MCMichel Carrier
Michel Carrier
PDPhilippe Demers
Philippe Demers

16 March 2021 in Membranes
Verified
Journal Article
Open access
PDF file
JBJuan Pablo Ricarte Bratti
Juan Pablo Ricarte Bratti
YCYiorgos Alexandros Cavayas
Yiorgos Alexandros Cavayas
pierre-emmanuel nolypierre-emmanuel noly
pierre-emmanuel noly
KSKarim Serri
Karim Serri
YLYoan Lamarche
Yoan Lamarche
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is used to sustain circulatory and respiratory support in patients with severe cardiogenic shock or refractory cardiac arrest. Although VA-ECMO allows adequate perfusion of end-organs, it may have detrimental effects on myocardial recovery. Hemodynamic consequences on the left ventricle, such as the increase of afterload, end-diastolic pressure and volume, can lead to left ventricular (LV) distention, increase of myocardial oxygen consumption and delayed LV function recovery. LV distention occurs in almost 50% of patients supported with VA-ECMO and is associated with an increase in morbidity and mortality. Thus, recognizing, preventing and treating LV distention is key in the management of these patients. In this review, we aim to discuss the pathophysiology of LV distention and to describe the strategies to unload the LV in patients supported with VA-ECMO.

1 May 2017 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
YLYoan Lamarche
Yoan Lamarche
MEMahsa Elmi-Sarabi
Mahsa Elmi-Sarabi
LDLillian Ding
Lillian Ding
JAJames G. Abel
James G. Abel
DSDemetrios Sirounis
Demetrios Sirounis
ADAndré Y. Denault
André Y. Denault

12 January 2015 in Trauma Monthly
Verified
Journal Article
Open access
PDF file
JFJessica Forcillo
Jessica Forcillo
MPMichel Philie
Michel Philie
AOAndrea Ojanguren
Andrea Ojanguren
SGSoazig Le Guillan
Soazig Le Guillan
AVAlain Verdant
Alain Verdant
YLYoan Lamarche
Yoan Lamarche
Background: Multiple classifications can be used to define the magnitude of aortic injury. The Vancouver Classification (VC) is a new and simplified computed tomography-based Blunt Aortic Injury (BAI) grading system correlating with clinical outcomes. Objectives: The objectives of this study are: 1) to describe the severity of aortic injury in a center with a predominantly surgical approach to BAI; 2) to correlate the severity of aortic trauma to hospital survival rate and rate of adverse events according to the type of interventions performed during the hospital stay; and 3) to evaluate VC. Patients and Methods: All patients referring to the Sacre-Coeur Hospital of Montreal between August 1998 and April 2011 for management of BAI were studied. Two radiologists reviewed all CT scan images individually and classified the aortic injuries using VC. Results: Among the 112 patients presenting with BAI, 39 cases had local CT scans available for reconstruction. Seven patients were identified as suffering from grade I injuries (flap or thrombus of less than 1 cm), 6 from grade II injuries (flap or thrombus of more than 1 cm), and 26 from grade III injuries (pseudoaneurysm). Among the patients with grade I injuries, 57% were treated surgically and 43% medically with a survival rate of 100%. Among the patients with grade II injuries (67% treated surgically and 33% treated medically) survival was also 100%. Among patients with grade III injuries (85% treated surgically, 7% had Thoracic Endovascular Aortic Repair (TEVAR) and 8% treated medically) survival was 95%, 95% and 50%, respectively. There were no significant differences between groups as to clinical outcome. Inter-rater reliability was 0.81. Conclusions: VC is easy to use and has low inter-observer variability. Low grades of injury were associated with low mortality related to medical treatment. Keywords: Thoracic Aorta; Trauma; Assessment Patient Outcomes

21 August 2017 in Asian Cardiovascular and Thoracic Annals
Verified
Journal Article
Closed access
NBNadia Bouabdallaoui
Nadia Bouabdallaoui
DBDenis Bouchard
Denis Bouchard
EJE. Marc Jolicoeur
E. Marc Jolicoeur
ACAlexandra Chronopoulos
Alexandra Chronopoulos
PGPierre Y Garneau
Pierre Y Garneau
YLYoan Lamarche
Yoan Lamarche
Extracorporeal membrane oxygenation has been extensively used for cardiopulmonary support in cardiogenic shock. However, its clinical value in the management of pheochromocytoma crisis remains unclear. We report a rare case of life-threatening cardiogenic shock managed with peripheral venoarterial extracorporeal membrane oxygenation combined with endovascular left ventricular venting, in a 40-year-old female patient, in the setting of unknown adrenal pheochromocytoma. We highlight the life-saving role of extracorporeal membrane oxygenation in undiagnosed endocrine emergencies, allowing cardiac and end-organ recovery, and giving time for accurate diagnosis and specific treatment in such unusual situations.

17 January 2023 in JTCVS Open
Verified
Journal Article
Open access
PDF file
ODOlina Dagher
Olina Dagher
PNPierre-Emmanuel Noly
Pierre-Emmanuel Noly
WAWalid Ben Ali
Walid Ben Ali
NBNadia Bouabdallaoui
Nadia Bouabdallaoui
LGLucian Geicu
Lucian Geicu
YLYoan Lamarche
Yoan Lamarche
Objective To evaluate the outcomes of patients supported with Impella (CP/5.0) or venoarterial extracorporeal membrane oxygenation (VA-ECMO) for cardiogenic shock according to shock phenotype. The primary end point was 30-day survival. Methods A retrospective study of patients supported with Impella (CP/5.0) or VA-ECMO between 2010 and 2020 was performed. Patients were grouped according to 1 of 2 shock phenotypes: isolated left ventricular (LV) dysfunction versus biventricular dysfunction or multiple organ failure (MOF). The local practice favors Impella for isolated LV dysfunction and VA-ECMO for biventricular dysfunction or MOF. Results Among the 75 patients included, 17 (23%) had isolated LV dysfunction. Patients with biventricular dysfunction or MOF had a greater median lactate level compared with those with isolated LV dysfunction (7.9 [2.9-11.8] vs 3.8 [1.1-5.8] mmol/L, respectively). Among patients with isolated LV dysfunction, 30-day survival was 46% for the Impella group (n = 13) and 75% for VA-ECMO (n = 4). Among patients with biventricular dysfunction or MOF, 30-day survival was 9% for the Impella group (n = 11) and 28% for VA-ECMO (n = 47). Patients supported with Impella 5.0 had better 30-day survival compared with those supported with Impella CP, for both shock phenotypes (83% vs 14% and 14% vs 0%, respectively). Conclusions In this small cohort, patients supported with Impella for isolated LV dysfunction and VA-ECMO for biventricular dysfunction or MOF had acceptable survival at 30 days. Patients with biventricular dysfunction or MOF who were supported by Impella had the lowest survival rates. Patients with isolated LV dysfunction who were supported with VA-ECMO had good 30-day survival.